Age-related macular degeneration (AMD) is a leading cause of age-related blindness worldwide. Global prevalence estimates suggest that approximately 196 million people were living with AMD in 2020; by 2040, it is expected that 288 million will be affected by the disease. AMD leads to irreversible destruction of the macula, resulting in the loss of the sharp, fine-detail, "straight ahead" vision that is required for activities such as reading, driving, recognizing faces, and seeing in color. Exudative or wet AMD, the advanced form of the disease, accounts for only 10% of cases but 90% of the vision loss that is attributed to AMD. Advances in the treatment of exudative AMD, such as intravitreal injections, have the potential to dramatically improve outcomes in this patient population.
How much do you know about intravitreal injection for exudative AMD? Test your knowledge with this quick quiz.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: F. Ryan Prall. Fast Five Quiz: Exudative Age-Related Macular Degeneration (Wet AMD) Intravitreal Injection - Medscape - Mar 01, 2021.
Comments